Highlights of agreement ASCEND’s IT software is used by 50,000 hospitals, clinics, and caregivers. Initial two-year term for North American markets. Ventripoint will be integrated into ASCEND’s IT for cardiovascular care. Toronto, Ontario – December 12, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV: VPT; OTC: VPTDF), now bringing its AI-powered heart-scanning technology to the world’s hospitals, is pleased to announce it has entered into a global

Toronto, Ontario – The Newswire – August 18, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC have developed a new integrated product. Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into Ventripoint’s roadmap for innovation and is a key step in the company’s miss

Toronto, Ontario – The Newswire – August 10, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and Ascend Cardiovascular, a leading provider of cardiovascular IT solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development initiatives, knowledge sharing, and combining efforts to bring innovative AI-based solutio

ASCEND Cardiovascular, a leader in cardiovascular structured reporting and workflow innovation, announces the issuance of a patent by the United States Patent and Trademark Office (USPTO), covering its AI-based solution for Categorical Hanging Image Protocols (CHIP). Using AI-based image analysis and machine learning, CHIP automatically categorizes adult Transthoracic Echo (TTE) images by view/modality. This allows ASCEND’s InView solution to intelligently organize and displa

ASCEND Cardiovascular, leader in cardiovascular structured reporting and workflow solutions is partnering with Us2.ai to add fully automated echocardiography analysis and CV disease detection reporting to its suite of seamlessly integrated cardiovascular image visualization and reporting solutions. When integrated with InViewTM, ASCEND’s high-performance zero-footprint Cardiovascular viewer, Us2.ai’s FDA-cleared and CE Marked echocardiogram algorithms automate measurements an

ASCEND Cardiovascular, a leader in innovating cardiovascular solutions that empower the provider community to improve cardiovascular care, will be showcasing its complete portfolio of solutions at the American College of Cardiology (ACC) annual meeting in New Orleans from March 4th – 6th, 2023. Designed with openness in mind, ASCEND’s solutions integrate with EHRs, medical devices, and other systems to deliver seamless workflows that span procedure types and modalities, inclu